Found: 109
Select item for more details and to access through your institution.
Migraine chronification as an allostatic disorder: a proof-of-concept study.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 6, p. 2775, doi. 10.1007/s10072-023-07293-8
- By:
- Publication type:
- Article
The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review.
- Published in:
- Pain & Therapy, 2024, v. 13, n. 3, p. 319, doi. 10.1007/s40122-024-00581-x
- By:
- Publication type:
- Article
Correction: The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2434, doi. 10.1007/s00415-023-12103-4
- By:
- Publication type:
- Article
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE study.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2605, doi. 10.1007/s00415-024-12192-9
- By:
- Publication type:
- Article
The first interim analysis of Italian patients enrolled in the real-world, Pan-European, prospective, observational, phase 4 PEARL study of fremanezumab effectiveness.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 5, p. 2353, doi. 10.1007/s10072-024-07357-3
- By:
- Publication type:
- Article
Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controls.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 4, p. 1645, doi. 10.1007/s10072-023-07152-6
- By:
- Publication type:
- Article
Is physiotherapy in migraines known to sufferers? A cross-sectional study.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 4, p. 1669, doi. 10.1007/s10072-023-07195-9
- By:
- Publication type:
- Article
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 415, doi. 10.1007/s40120-024-00582-0
- By:
- Publication type:
- Article
Spontaneous Intracranial Hypotension and Subdural Hematomas Treatment Management Using MMA Embolization and Target Blood Patch: A Case Report.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 2, p. 250, doi. 10.3390/life14020250
- By:
- Publication type:
- Article
The evolutionary meaning of migraine.
- Published in:
- Cephalalgia, 2023, v. 43, n. 12, p. 1, doi. 10.1177/03331024231209303
- By:
- Publication type:
- Article
Vessel‐wall MRI in primary headaches: The role of neurogenic inflammation.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1372, doi. 10.1111/head.14253
- By:
- Publication type:
- Article
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 11, p. 5436, doi. 10.1007/s00415-023-11872-2
- By:
- Publication type:
- Article
Prevalence, natural history and dynamic nature of chronic headache and medication overuse headache in Italy: The SPARTACUS study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 4, p. 1, doi. 10.1177/03331024231157677
- By:
- Publication type:
- Article
INPH and parkinsonism: A positive shunt response with a negative tap test.
- Published in:
- Frontiers in Neurology, 2023, v. 14, p. 1, doi. 10.3389/fneur.2023.1150258
- By:
- Publication type:
- Article
Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 1, p. 224, doi. 10.1111/ene.15563
- By:
- Publication type:
- Article
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01498-6
- By:
- Publication type:
- Article
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 11, p. 5848, doi. 10.1007/s00415-022-11226-4
- By:
- Publication type:
- Article
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome.
- Published in:
- Fluids & Barriers of the CNS, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12987-022-00368-2
- By:
- Publication type:
- Article
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study.
- Published in:
- Cephalalgia, 2022, v. 42, n. 10, p. 1058, doi. 10.1177/03331024221093712
- By:
- Publication type:
- Article
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 17, p. 10975, doi. 10.3390/ijerph191710975
- By:
- Publication type:
- Article
The ultimate guide to the anti-CGRP monoclonal antibodies galaxy.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 9, p. 5673, doi. 10.1007/s10072-022-06199-1
- By:
- Publication type:
- Article
Greater occipital nerve blockade in cluster headache: effectiveness and safety of a combined injection protocol.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 9, p. 5777, doi. 10.1007/s10072-022-06198-2
- By:
- Publication type:
- Article
Gait apraxia evaluation in normal pressure hydrocephalus using inertial sensors. Clinical correlates, ventriculoperitoneal shunt outcomes, and tap-test predictive capacity.
- Published in:
- Fluids & Barriers of the CNS, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12987-022-00350-y
- By:
- Publication type:
- Article
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache.
- Published in:
- Cephalalgia, 2022, v. 42, n. 7, p. 645, doi. 10.1177/03331024211067791
- By:
- Publication type:
- Article
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 4, p. 1198, doi. 10.1111/ene.15197
- By:
- Publication type:
- Article
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 4, p. 2193, doi. 10.1007/s00415-021-10884-0
- By:
- Publication type:
- Article
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01408-w
- By:
- Publication type:
- Article
When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?
- Published in:
- Journal of Neurology, 2022, v. 269, n. 2, p. 1032, doi. 10.1007/s00415-021-10772-7
- By:
- Publication type:
- Article
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 2, p. 1273, doi. 10.1007/s10072-021-05426-5
- By:
- Publication type:
- Article
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01363-y
- By:
- Publication type:
- Article
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.774341
- By:
- Publication type:
- Article
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients.
- Published in:
- Pain & Therapy, 2021, v. 10, n. 2, p. 1605, doi. 10.1007/s40122-021-00328-y
- By:
- Publication type:
- Article
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1351, doi. 10.1111/head.14194
- By:
- Publication type:
- Article
The unforgivable curse of Harry Potter's thunderclap headaches.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 8, p. 2671, doi. 10.1007/s00415-020-10248-0
- By:
- Publication type:
- Article
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real‐life perspective from the Italian chROnic migraiNe (IRON) project.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 6, p. 936, doi. 10.1111/head.14123
- By:
- Publication type:
- Article
Do anti-CGRP drugs have a role in migraine aura therapy?
- Published in:
- 2021
- By:
- Publication type:
- Letter
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study.
- Published in:
- Pain & Therapy, 2021, v. 10, n. 1, p. 637, doi. 10.1007/s40122-021-00253-0
- By:
- Publication type:
- Article
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01247-1
- By:
- Publication type:
- Article
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.647995
- By:
- Publication type:
- Article
Vessel-wall MRI in thunderclap headache: A useful tool to answer the riddle?
- Published in:
- Interventional Neuroradiology, 2021, v. 27, n. 2, p. 219, doi. 10.1177/1591019920979496
- By:
- Publication type:
- Article
Anterior callosal angle correlates with gait impairment and fall risk in iNPH patients.
- Published in:
- Acta Neurochirurgica, 2021, v. 163, n. 3, p. 759, doi. 10.1007/s00701-020-04699-7
- By:
- Publication type:
- Article
Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 2, p. 363, doi. 10.1111/head.14032
- By:
- Publication type:
- Article
A Randomized Clinical Trial on Acupuncture Versus Best Medical Therapy in Episodic Migraine Prophylaxis: The ACUMIGRAN Study.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.570335
- By:
- Publication type:
- Article
Acupuncture vs. Pharmacological Prophylaxis of Migraine: A Systematic Review of Randomized Controlled Trials.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.576272
- By:
- Publication type:
- Article
Moving closer to the ideal migraine acute treatment.
- Published in:
- Neurological Sciences, 2020, v. 41, p. 381, doi. 10.1007/s10072-020-04650-9
- By:
- Publication type:
- Article
Erenumab efficacy in highly resistant chronic migraine: a real-life study.
- Published in:
- Neurological Sciences, 2020, v. 41, p. 457, doi. 10.1007/s10072-020-04658-1
- By:
- Publication type:
- Article